Ticker

CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced the formation of a Scientific Advisory Board (SAB) to provide strategic counsel and insights into the development of Lineage's novel…

U.S. equity markets extended their rebound this week as investors welcomed tentative progress toward de-escalation in the Middle East following several days of dramatic threats of significant escalation. The fragile pause in hostilities temporarily eased fears of a prolonged disruption to global energy supplies and fueled a sharp retreat in oil prices after a surge to four-year highs. Markets also found support from…

New York, New York--(Newsfile Corp. - April 9, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Lineage, Inc. (NASDAQ: LINE) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Lineage caused the company to misrepresent or fail to disclose that Lineage's financial and operational results had been…

NOVI, Mich.--(BUSINESS WIRE)--Lineage, Inc. (NASDAQ: LINE) (“Lineage” or the "Company"), the world's largest global temperature-controlled warehouse REIT, today announced the planned retirement of its Chief Information Officer and Chief Transformation Officer, Sudarsan Thattai. The Company will implement a phased transition to maintain momentum across mission-critical initiatives and provide a smooth and…

Lineage, Inc. (LINE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).